• Introduction to Long-Acting Injectables

    This infographic details the process for developing long-acting injectables for pre-exposure prophylaxis and treatment.

  • HPTN 083 Summary

    The HIV Prevention Trials Network (HPTN) is conducting a Phase 2b/3 double-blind safety and efficacy study of injectable cabotegravir compared to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis among HIV-uninfected cisgender men and transgender women who have sex with men.